Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 4.56% vs 14.14% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 10.00% vs 25.41% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -8.02% vs 25.58% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs -14.29% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Chengdu Easton Biopharmaceuticals Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 4.56% vs 14.14% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -1.54% vs 25.82% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 10.00% vs 25.41% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 18.58% vs 13.34% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -8.02% vs 25.58% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 0.81% vs 16.19% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs -14.29% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -25.00% vs -11.11% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






